We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Missouri Implements New Rules for Final Cannabis License Lottery
about 20 hours ago
Lahontan Gold Poised for Growth with Scalable Satellite Deposit Strategy
about 21 hours ago
Optimi Health Hails TGA Framework Expansion for Psychedelic Therapies
about 21 hours ago
Regentis Biomaterials Advances GelrinC for Knee Cartilage Repair
about 21 hours ago
Planet Ventures Targets Space Sector Growth with Portfolio Strategy
about 21 hours ago
Aegis Capital Brokers $15M Secondary Sale of Perplexity AI Stake
about 22 hours ago
HR News
Unlock Veteran Talent: Free Hiring Pipeline in Texas
1 day ago
UKG's 950-Employee Restructuring Signals Shift to Small Business HCM
3 days ago
Amadeus Fire Extends Gerlitzki's Board Contract Early Through 2031
4 days ago
Liveops Launches Flexible Outsourced Call Center Model
5 days ago
HRO Today's 2026 Talent Acquisition Summit Set for Atlanta
10 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in about 12 hours
12 Diverse Small-Cap Companies to Present at June 4 Virtual Investor Conference
about 18 hours ago
Lahontan Gold Poised for Growth with Scalable Satellite Deposit Strategy
about 21 hours ago
Crypto News
Institutional Investors Cautiously Warm to Crypto, Survey Finds
1 day ago
Crypto Markets Rally on Hopes of US-Iran Deal
1 day ago
SEC Delays Crypto Stock Exemptions Amid Wall Street Concerns
2 days ago
SOLOWIN HOLDINGS Eyes Stablecoin Integration in Bahrain Payments
3 days ago
Forward Industries to Join Russell 2000 and 3000 Indexes
4 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in about 12 hours
Regentis Biomaterials Advances GelrinC for Knee Cartilage Repair
about 21 hours ago
Regentis Biomaterials' GelrinC® Poised to Transform Knee Cartilage Repair
1 day ago
Technology News
Planet Ventures Targets Space Sector Growth with Portfolio Strategy
about 21 hours ago
IEA Predicts 23 Million EV Sales Globally in 2026
1 day ago
AI Boom Drives Two Chip Firms Into Trillion-Dollar Club
1 day ago
ParaZero Technologies Ramps Up DefendAir Production for Drone Defense
1 day ago
Redwood AI to Acquire Quantum.IQ, Bolstering Quantum Cybersecurity
1 day ago
Events & Conferences
Waco Surf's Sold-Out Waves: From Struggling Pool to Texas Destination
about 4 hours ago
12 Diverse Small-Cap Companies to Present at June 4 Virtual Investor Conference
about 18 hours ago
Blockchain Futurist Conference Returns to Florida in 2026
1 day ago
Unlock Veteran Talent: Free Hiring Pipeline in Texas
1 day ago
Amadeus Fire AG AGM Approves New Capital and Strategy
2 days ago